Novocuff Raises $26 Million in Oversubscribed Series A Funding to Advance Technology Aimed at Reducing Preterm Births
Donald Lee (COO) & Amelia Degenkolb (CEO), Novocuff Co-Founders (Photo: Business Wire) MOUNTAIN VIEW, Calif., July 17, 2024–(BUSINESS WIRE)–Novocuff, Inc., a medical device company dedicated to improving pregnancy outcomes and reducing the risk of preterm birth, has successfully closed an oversubscribed $26 million Series A funding round after raising an initial $2 million seed round.
